Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial

BACKGROUND: Rituximab plus cyclophosphamide, vincristine, and prednisone (R-CVP) is one of the effective chemotherapeutic regimens for patients with advanced stage marginal zone lymphoma (MZL). However, prognostic factors that affect the outcome of treatment for MZL are not well understood. METHODS:...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Res
Main Authors: Seo, Jeongkuk, Kim, Won Seog, Kim, Jin Seok, Kim, Seok Jin, Lee, Jae Hoon, Hong, Jun Shik, Lee, Gyeong-Won, Oh, Sung Yong, Lee, Ji-Hyun, Yoon, Dok Hyun, Lee, Won-Sik, Kim, Hyo Jung, Kwak, Jae-Yong, Kang, Hye Jin, Jo, Jae-Cheol, Park, Yong, Lee, Ho Sup, Kim, Hyo-Jin, Suh, Cheolwon
Format: Artigo
Sprog:Inglês
Udgivet: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2017
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5641512/
https://ncbi.nlm.nih.gov/pubmed/29043235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2017.52.3.200
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker